Skip to main content
SpringerLink
Log in

HCV therapy cost effective in patients with early fibrosis

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2014 US dollars

References

  1. Chahal HS, et al. Cost-effectiveness of Early Treatment of Hepatitis C Virus Genotype 1 by Stage of Liver Fibrosis in a US Treatment-Naive Population. JAMA Internal Medicine : 23 Nov 2015. Available from: URL: http://doi.org/10.1001/jamainternmed.2015.6011

    Google Scholar 

  2. Yee HF. Treatment of Hepatitis C Virus Infection in Real Life. JAMA Internal Medicine : 23 Nov 2015. Available from: URL: http://dx.doi.org/10.1001/jamainternmed.2015.6659

    PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

HCV therapy cost effective in patients with early fibrosis. PharmacoEcon Outcomes News 743, 21 (2015). https://doi.org/10.1007/s40274-015-2686-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-015-2686-5

Search

Navigation